Show simple item record

dc.contributor.authorAnderson, Heather
dc.contributor.authorPrice, Patricia M
dc.date.accessioned2009-09-08T08:58:53Z
dc.date.available2009-09-08T08:58:53Z
dc.date.issued2002-02
dc.identifier.citationClinical measurement of blood flow in tumours using positron emission tomography: a review. 2002, 23 (2):131-8 Nucl Med Communen
dc.identifier.issn0143-3636
dc.identifier.pmid11891466
dc.identifier.urihttp://hdl.handle.net/10541/80215
dc.description.abstractIn oncology drug development there is an increasing need for the in vivo physiological measurement of changes in tumour blood flow in response to therapy. Positron Emission Tomography (PET) is being increasingly used in oncology patients to measure blood flow. Here we review the clinical use of PET to measure vascular parameters in man.
dc.language.isoenen
dc.subjectBreast Canceren
dc.subjectGastrointestinal Canceren
dc.subject.meshBreast Neoplasms
dc.subject.meshCerebrovascular Circulation
dc.subject.meshCoronary Circulation
dc.subject.meshGastrointestinal Neoplasms
dc.subject.meshHumans
dc.subject.meshModels, Cardiovascular
dc.subject.meshRadiopharmaceuticals
dc.subject.meshRegional Blood Flow
dc.subject.meshTomography, Emission-Computed
dc.titleClinical measurement of blood flow in tumours using positron emission tomography: a review.en
dc.typeArticleen
dc.contributor.departmentCRC PET Oncology Group, MRC Cyclotron Unit, Imperial College School of Medicine, Hammersmith Hospital, Du Cane Rd, London W12 0NN, UK.en
dc.identifier.journalNuclear Medicine Communicationsen
html.description.abstractIn oncology drug development there is an increasing need for the in vivo physiological measurement of changes in tumour blood flow in response to therapy. Positron Emission Tomography (PET) is being increasingly used in oncology patients to measure blood flow. Here we review the clinical use of PET to measure vascular parameters in man.


This item appears in the following Collection(s)

Show simple item record